As hopes for an end to the trade war between the US and China increase, the stock markets reflected the sentiment with gains at the outset of the new year. Find out more in the new blog entry.
ARTICLES IN THE TOPIC “Equities”
Low Return on Assets – where can savers still find decent interest rates?
Many savers are fed up with investing their saved-up capital at low interest rates. The question everyone is asking themselves now is how to earn a good yield on one’s hard-earned capital in times of low interest rates like nowadays?
European banking overshadowed by Italian banks
The year started strongly for European markets with investors favoring Italian banks and stocks. But then came the budget proposal of the new Italian government, changing the mood abruptly. Read about it in our new blog!
Changes in the MSCI Emerging Markets Index
In 1988, MSCI Emerging Markets Index was launched and consisted of just 10 countries representing less than 1% of world market capitalization. Today the index consists of 24 countries representing 10% of world market capitalization. Read here about the changes expected until June 2020 to one of the most important global emerging markets equities index.
The technology cycle is not over for a while
How does Bernhard Ruttenstorfer, senior fund manager of our technology fund, see the future of technology shares? Find out here.
Mixed feelings on the US stock exchanges
After a good start to the US reporting season, the tide on the US stock exchanges turned last week. Find out more in our new blog.
Stirred, not shaken – A first take on last week’s stock market meltdown
Last week, the S&P 500 lost more than 3%, followed by another loss of more than 2% on the next day. Read about the reasons behind this decrease in our new blog!
US Federal Reserve with the third interest rate hike this year
The central bankers’ assessments regarding inflation and the labour market are considered important indicators for future interest rate policy. More on our blog.
Possible breakthrough in gene technology driving biotechnology share prices
Biotech shares are regarded as highly promising due to the innovative strength of the sector, but they also tend to be subject to drastic price fluctuations both ways. After a long period of consolidation, biotech shares have embarked on a clear upward trend since May 2018. Harald Kober, Senior Fund Manager, explains the reasons for the investors’ optimism.
European equities – still time to get on board?
The performance of European equities in the year to date has been disappointing. While in the USA stock exchanges are going from strength to strength, European share prices have been stagnating. Is it still worth investing in European equities?